Diseases such as cancer and neurodegenerative disorders often begin with genetic mistakes. But even after scientists identify the genes involved, turning that knowledge into effective treatments has remained extremely difficult. Many of these diseases are linked to hundreds of mutations spread across different biological pathways, making it hard to understand how they collectively drive disease.
A new study published in Nature introduces a potential solution. Researchers created a platform called PerturbFate that can systematically track how disease related genetic changes alter cells and identify where those changes ultimately converge. By observing gene regulation in single cells over time, the team uncovered shared regulatory hubs that many different mutations depend on. Using melanoma drug resistance as a test case, the researchers showed that targeting these common control points could help overcome resistance across multiple genetic causes.
"We focus here on cancer drug resistance, but the paper really starts from a broader question: once you know that a disease is associated with hundreds of genes, how do you design one therapy to target it?" says Junyue Cao, head of the Laboratory of Single-Cell Genomics and Population Dynamics. "We wondered whether all these different genes may be mediated by some shared downstream signaling that we can discover and target instead."
